Brief: Thermo Fisher Scientific To Commercialize Devyser's Post-Transplant NGS Products
April 24 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* ENTERS AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR COMMERCIALIZATION OF DEVYSER'S
POST-TRANSPLANT NGS PRODUCTS
* THERMO FISHER SCIENTIFIC OBTAINS EXCLUSIVE RIGHTS TO COMMERCIALIZE DEVYSER'S
POST-TRANSPLANT
MONITORING PORTFOLIO IN NORTH AMERICA AND EUROPE.
Source text for Eikon: ID:nWkr4Z0L6t
Further company coverage: DVYSR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue